Enhanced immunogenicity of the tuberculosis subunit Rv0572c vaccine delivered in DMT liposome adjuvant as a BCG-booster

COVID-19 has affected the progress made in the prevention and treatment of tuberculosis (TB); hence, the mortality of tuberculosis has risen. Different strategies-based novel TB vaccine candidates have been developed. This study identifies strategies to overcome the limitations of Bacille Calmette-G...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Lirong, Xu, Lifa, Wang, Xiaochun, Xing, Yingru, Wang, Jian, Zhang, Yanpeng, Yuan, Wei, Du, Jianpeng, Shi, Zilun, Ma, Jilei, Zhang, Jingyan, Zhang, Xiaohan, Wang, Xinping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881818/
https://www.ncbi.nlm.nih.gov/pubmed/35245739
http://dx.doi.org/10.1016/j.tube.2022.102186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881818/
https://www.ncbi.nlm.nih.gov/pubmed/35245739
http://dx.doi.org/10.1016/j.tube.2022.102186

Ejemplares similares